The Society of Surgical Oncology (SSO) Clinical Investigator Award 2027 supports patient-focused research conducted by surgical oncologists in clinical and translational science.
Beginning with the 2027 cycle, SSO increased the award to $150,000 over two years, expanding support for investigator-initiated research aimed at advancing surgical oncology and improving cancer care.
Eligibility Criteria
- Applicants must be surgical oncologists.
- Applicants must be within 8 years of completing fellowship or related training.
- Applicants must be SSO U.S. members in good standing.
- Proposed research should be patient-focused.
- Projects must fall within clinical or translational cancer research.
- Applicants should demonstrate the potential of the proposed work to advance surgical oncology or cancer care.
Funding Details
- Funding: $150,000 total
- Annual funding: $75,000 per year
- Duration: 2 years
- Award period begins April 1, 2027
- Award concludes March 31, 2029.
Deadline
- Applications opened: August 17, 2026
- Application deadline: October 2, 2026
- Finalist presentations: December 2, 2026
- Recipients notified: December 2026
- Recipients announced: January 2027.
Further Information
- Selected finalists are invited to present their proposed research to the SSO Research Committee.
- The award supports clinical and translational science, rather than basic laboratory research alone.
- SSO increased the 2027 award from the previous $100,000 to $150,000.
- Applications are submitted through the SSO online application system.
- Official SSO Clinical Investigator Award.